91 related articles for article (PubMed ID: 6733674)
1. Solid tumor models for the assessment of different treatment modalities. XXII. The alternate utilization of radiotherapy and chemotherapy.
Looney WB; Hopkins HA; Carter WH
Cancer; 1984 Aug; 54(3):416-25. PubMed ID: 6733674
[TBL] [Abstract][Full Text] [Related]
2. Solid tumor models for the assessment of different treatment modalities: XXIII. A new approach to the more effective utilization of radiotherapy alternated with chemotherapy.
Looney WB; Hopkins HA; Carter WH
Int J Radiat Oncol Biol Phys; 1985 Dec; 11(12):2105-17. PubMed ID: 4066443
[TBL] [Abstract][Full Text] [Related]
3. Solid tumor models for the assessment of different treatment modalities. XXI. Comparison of different radiation dose schedules alone or in combination with cyclophosphamide.
Looney WB; Longerbeam MB; Hopkins HA; Carter WH
Cancer; 1983 Mar; 51(6):1012-20. PubMed ID: 6821865
[TBL] [Abstract][Full Text] [Related]
4. Solid tumor models for the assessment of different treatment modalities: XVI. Sequential combined modality (Cyclophosphamide-Radiation) therapy.
Looney WB; Ritenour ER; Hopkins HA
Cancer; 1981 Mar; 47(5):860-9. PubMed ID: 7226039
[TBL] [Abstract][Full Text] [Related]
5. Comparison of effects of daily versus hyperfractionated split-course radiation schedules with and without cyclophosphamide on median survival, metastatic dissemination, tumor cure, and growth rates.
Looney WB; Hopkins HA; Longerbeam MB; Carter WH
Cancer Res; 1983 Jan; 43(1):60-7. PubMed ID: 6847784
[TBL] [Abstract][Full Text] [Related]
6. Solid tumor models for the assessment of different treatment modalities: XXV. Comparison of the effect of one radiation fraction per day with multiple fractions per day (MFD) given either continuously or intermittently on tumor response and normal tissue reaction.
Looney WB; Hopkins HA
Int J Radiat Oncol Biol Phys; 1986 Feb; 12(2):203-10. PubMed ID: 3949571
[TBL] [Abstract][Full Text] [Related]
7. Administration of radiation or cyclophosphamide versus alternated radiation and cyclophosphamide treatment of primary tumor and pulmonary metastases.
Looney WB; Hopkins HA
NCI Monogr; 1988; (6):145-6. PubMed ID: 3352757
[TBL] [Abstract][Full Text] [Related]
8. Solid tumor models for the assessment of different treatment modalities. XIX. Tumor cure rates and tumor control following sequential administration of radiation and cyclophosphamide.
Looney WB; Ritenour ER; Hopkins HA
Am J Clin Oncol; 1982 Apr; 5(2):209-20. PubMed ID: 7091043
[TBL] [Abstract][Full Text] [Related]
9. Relationship of tumor regrowth to tumor cell survival, tumor cure rates and host survival in a solid tumor model following combined chemotherapy and radiotherapy.
Hopkins HA; Looney WB; Carter WH; Reto DC; Campbell ED
In Vivo; 1994; 8(1):97-105. PubMed ID: 8054518
[TBL] [Abstract][Full Text] [Related]
10. Solid tumor models for the assessment of different treatment modalities. XIII. Comparison of response and recovery of host and solid tumor to cyclophosphamide and radiation.
Looney WB; Hopkins HA; Grover WH; Macleod MS; Ritenour ER; Hobson AS
Cancer; 1980 Jun; 45(11):2793-804. PubMed ID: 7379010
[TBL] [Abstract][Full Text] [Related]
11. Multiple drug chemotherapy combined with multiple fractions per day (MFD) radiotherapy in an experimental solid tumor model.
Hopkins HA; Looney WB; Carter WH; Reto DC; Campbell ED
In Vivo; 1994; 8(1):107-12. PubMed ID: 8054501
[TBL] [Abstract][Full Text] [Related]
12. Solid tumor models for the assessment of different treatment modalities: XXVI. Estimates of cell survival from tumor growth delay after alternating radiotherapy and chemotherapy.
Hopkins HA; Looney WB
Int J Radiat Oncol Biol Phys; 1987 Feb; 13(2):217-24. PubMed ID: 3818388
[TBL] [Abstract][Full Text] [Related]
13. Experimental and clinical studies alternating chemotherapy and radiotherapy.
Looney WB; Hopkins HA; Tubiana M
Cancer Metastasis Rev; 1989 Jun; 8(1):53-79. PubMed ID: 2667785
[TBL] [Abstract][Full Text] [Related]
14. Pilot study of multiple-fraction daily radiotherapy alternating with chemotherapy in patients with stage IV non-oat cell lung cancer.
Arcangeli G; Righini R; Nervi C; Guerra A; Tirindelli D; Hopkins H; Looney W
Cancer Treat Rep; 1985 Jan; 69(1):25-31. PubMed ID: 2981618
[TBL] [Abstract][Full Text] [Related]
15. Rationale for different chemotherapeutic and radiation therapy strategies in cancer management.
Looney WB; Hopkins HA
Cancer; 1991 Mar; 67(6):1471-83. PubMed ID: 2001534
[TBL] [Abstract][Full Text] [Related]
16. Alternating chemotherapy and radiotherapy.
Looney WB
NCI Monogr; 1988; (6):85-94. PubMed ID: 3352793
[TBL] [Abstract][Full Text] [Related]
17. Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer.
Choi NC; Herndon JE; Rosenman J; Carey RW; Chung CT; Bernard S; Leone L; Seagren S; Green M
J Clin Oncol; 1998 Nov; 16(11):3528-36. PubMed ID: 9817271
[TBL] [Abstract][Full Text] [Related]
18. Solid tumor models for the assessment of different treatment modalities: systematics of response to radiotherapy and chemotherapy.
Looney WB; Trefil JS; Schaffner JG; Kovacs CJ; Hopkins HA
Proc Natl Acad Sci U S A; 1976 Mar; 73(3):818-22. PubMed ID: 176656
[TBL] [Abstract][Full Text] [Related]
19. Changes in growth rate of an experimental solid tumor following increasing doses of cyclophosphamide.
Looney WB; Ritenour ER; Hopkins HA
Cancer Res; 1980 Jul; 40(7):2179-83. PubMed ID: 7388785
[TBL] [Abstract][Full Text] [Related]
20. Solid tumour models for the assessment of different treatment modalities: IV. the combined effects of radiation and 5-fluorouracil.
Looney WB; Schaffner JG; Trefil JS; Kovacs CJ; Hopkins HA
Br J Cancer; 1976 Sep; 34(3):254-61. PubMed ID: 184808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
